100P Characteristics and outcomes of patients (pts) with NTRK fusion-positive (NTRK+) metastatic / locally advanced (LA) solid tumours receiving non-TRK inhibitor (TRKi) standard of care (SoC), and prognostic value of NTRK fusions in clinical practice
| Autor: | Demetri, G.D., Peters, S., Hibbar, D.P., Davies, J., Maund, S.L., Veronese, L., Liu, H., Humblet, O., Perez, L. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S399-S399 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|